AEROSIL® 200 Pharma
AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products whichfulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. Eur.), United States Pharmacopeia (USP/NF), Japanese Pharmacopeia (JP) and Indian Pharmacopoeia** (IP). It is tested and certified according to pharmacopoeia methods. It fulfils purity criteria of E551 according to 231/2012 EU. In our production location in Rheinfelden, Germany AEROSIL® 200 Pharma is manufactured and packaged according to IPEC/GMP and HACCP/FAMI-QS guidelines. The production and packaging process has been audited and fulfills the requirements of regulation EC No. 852/2004. TAMC (total aerobic microbial count) , TYMC (total combined yeast and mould count) and Gram-negative bacteria are tested on a regular basis acc. to USP.
Scope of Application
Applications Pharmacy, all types of dosage forms Food** Feed** Properties Free flow and anti-caking agent to improve powder properties Improves tablet properties such as hardness and friability Used as viscosity increasing agent to thicken and thixotropize liquids Used as anti-setting, thickening and anti-sagging agent High purity, low humidity content No influence on taste Does not alter natural colour of powder formulations
The Closest Insight
Order product samples
All our product documentation
Find formulation concepts, videos and interactive online tools